On August 31, 2023 Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, reported its participation in the following upcoming investor conferences in September 2023 (Press release, Kineta, AUG 31, 2023, View Source;utm_medium=rss&utm_campaign=kineta-to-participate-in-upcoming-investor-conferences [SID1234634800]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 25th Annual Global Investment Conference
Format: Corporate presentation and investor meetings
Location: New York, NY
Date: Wednesday, September 13, 2023
Time: 11:00-11:30 A.M. Eastern Time

Northland Capital Markets Institutional Investor Conference – VIRTUAL
Format: Investor meetings
Date: Tuesday, September 19, 2023